Veru Announces Acceptance of Two Abstracts for Presentation at the 39th Miami Breast Cancer Conference
04.03.2022 - MIAMI, March 04, 2022 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancers, today announced that two abstracts were accepted ... Seite 1
International Phase Veru Inc Presentation Title Enobosarm Versus Active Control Breast Cancer Patients Who Previously Received
Source: wallstreet-online.de